These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38430106)

  • 1. Efficacy of omalizumab for the treatment of bullous pemphigoid: Spanish multicentre real-world experience.
    Aguado Vázquez Á; Estébanez Corrales A; Melgosa Ramos FJ; Mascaró Galy JM; Fulgencio-Barbarin J; Bosch Amate X; Curto Barredo L; Blanes-Martínez M; Ruiz-Villaverde R; Ballester Martínez A; Martín-Torregrosa D; Castaño Fernández JL; Cabeza Martínez R; Pérez-Ferriols A; Ramos Rodríguez D; Boix Vilanova J; Melé-Ninot G; Expósito Serrano V; España Alonso A; Mateu-Puchades A
    Clin Exp Dermatol; 2024 Aug; 49(9):1002-1006. PubMed ID: 38430106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab as a corticosteroid-sparing agent in the treatment of bullous pemphigoid.
    Vassallo C; Somenzi A; De Amici M; Barruscotti S; Brazzelli V
    Dermatol Ther; 2022 Dec; 35(12):e15946. PubMed ID: 36259470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
    Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
    Front Immunol; 2022; 13():874108. PubMed ID: 35514989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.
    Balakirski G; Alkhateeb A; Merk HF; Leverkus M; Megahed M
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1778-1782. PubMed ID: 27357866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress of omalizumab in the treatment of bullous pemphigoid.
    Ling X; Shou X; Lou Y; Ling J; Zhang M; Yu T; Gu W
    J Dermatol; 2023 May; 50(5):575-587. PubMed ID: 36971190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety.
    D'Aguanno K; Gabrielli S; Ouchene L; Muntyanu A; Ben-Shoshan M; Zhang X; Iannattone L; Netchiporouk E
    J Cutan Med Surg; 2022; 26(4):404-413. PubMed ID: 35379011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE blockade in autoimmunity: Omalizumab induced remission of bullous pemphigoid.
    James T; Salman S; Stevenson B; Bundell C; Kelly G; Nolan D; John M
    Clin Immunol; 2019 Jan; 198():54-56. PubMed ID: 30557620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid.
    Seyed Jafari SM; Gadaldi K; Feldmeyer L; Yawalkar N; Borradori L; Schlapbach C
    Front Immunol; 2019; 10():1919. PubMed ID: 31474990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab in the treatment of bullous pemphigoid: A single-center series of 15 cases.
    Altan Ferhatoglu Z; Yucesoy SN; Ak T; Demir Y
    Medicine (Baltimore); 2024 Jul; 103(30):e38684. PubMed ID: 39058846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological treatment for bullous pemphigoid.
    Oren-Shabtai M; Mimouni D; Nosrati A; Atzmony L; Kaplan B; Barzilai A; Baum S
    Front Immunol; 2023; 14():1157250. PubMed ID: 37180101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report.
    Vico-Alonso C; Calleja-Algarra A; Aragón-Miguel R; Sánchez-Velázquez A; Velasco-Tamariz V; Ortiz-Romero PL; Monsálvez-Honrubia V
    Dermatol Ther; 2019 Mar; 32(2):e12829. PubMed ID: 30659716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments.
    Bilgiç Temel A; Bassorgun CI; Akman-Karakaş A; Alpsoy E; Uzun S
    Case Rep Dermatol; 2017; 9(1):38-44. PubMed ID: 28413387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab therapy for bullous pemphigoid.
    Yu KK; Crew AB; Messingham KA; Fairley JA; Woodley DT
    J Am Acad Dermatol; 2014 Sep; 71(3):468-74. PubMed ID: 24954907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].
    Neumark M; Tal Y; Zlotogorski A; Molho-Pessach V
    Harefuah; 2020 Jan; 159(1):29-30. PubMed ID: 31930804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Omalizumab Successfully Treated Recalcitrant Bullous Pemphigoid in an Elderly Patient with Multiple Comorbidities.
    Liu J; Xiang T; Wang W; Bu Z
    Clin Cosmet Investig Dermatol; 2022; 15():1391-1396. PubMed ID: 35903519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature.
    Kremer N; Snast I; Cohen ES; Hodak E; Mimouni D; Lapidoth M; Mazor S; Levi A
    Am J Clin Dermatol; 2019 Apr; 20(2):209-216. PubMed ID: 30421306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IgE in bullous pemphigoid: a review and rationale for IgE directed therapies.
    Messingham KN; Pietras TA; Fairley JA
    G Ital Dermatol Venereol; 2012 Jun; 147(3):251-7. PubMed ID: 22648326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.
    Cao P; Xu W; Zhang L
    Front Immunol; 2022; 13():928621. PubMed ID: 35769474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series.
    Akin G; Avci C; Akarsu S
    Indian J Dermatol; 2024; 69(1):81-85. PubMed ID: 38572025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.